1. Home
  2. CELH vs CYTK Comparison

CELH vs CYTK Comparison

Compare CELH & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELH
  • CYTK
  • Stock Information
  • Founded
  • CELH 2004
  • CYTK 1997
  • Country
  • CELH United States
  • CYTK United States
  • Employees
  • CELH N/A
  • CYTK N/A
  • Industry
  • CELH Beverages (Production/Distribution)
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • CELH Consumer Staples
  • CYTK Health Care
  • Exchange
  • CELH Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • CELH 5.3B
  • CYTK 5.0B
  • IPO Year
  • CELH N/A
  • CYTK 2004
  • Fundamental
  • Price
  • CELH $32.62
  • CYTK $50.26
  • Analyst Decision
  • CELH Strong Buy
  • CYTK Strong Buy
  • Analyst Count
  • CELH 18
  • CYTK 17
  • Target Price
  • CELH $48.94
  • CYTK $82.00
  • AVG Volume (30 Days)
  • CELH 12.4M
  • CYTK 1.9M
  • Earning Date
  • CELH 02-20-2025
  • CYTK 02-27-2025
  • Dividend Yield
  • CELH N/A
  • CYTK N/A
  • EPS Growth
  • CELH N/A
  • CYTK N/A
  • EPS
  • CELH 0.45
  • CYTK N/A
  • Revenue
  • CELH $1,355,630,000.00
  • CYTK $3,219,000.00
  • Revenue This Year
  • CELH $5.08
  • CYTK N/A
  • Revenue Next Year
  • CELH $15.38
  • CYTK $754.18
  • P/E Ratio
  • CELH $72.49
  • CYTK N/A
  • Revenue Growth
  • CELH 2.85
  • CYTK N/A
  • 52 Week Low
  • CELH $21.10
  • CYTK $40.53
  • 52 Week High
  • CELH $99.62
  • CYTK $81.36
  • Technical
  • Relative Strength Index (RSI)
  • CELH 72.79
  • CYTK 58.40
  • Support Level
  • CELH $22.25
  • CYTK $45.05
  • Resistance Level
  • CELH $26.22
  • CYTK $48.30
  • Average True Range (ATR)
  • CELH 1.32
  • CYTK 2.80
  • MACD
  • CELH 0.96
  • CYTK 0.61
  • Stochastic Oscillator
  • CELH 86.36
  • CYTK 86.80

About CELH Celsius Holdings Inc.

Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: